February 11, 2016

The Senate Judiciary Committee approved a piece of legislation aimed at curbing prescription drug abuse and ensuring legitimate patient access by encouraging collaboration between health and enforcement agencies. 

February 10, 2016

Specialty pharmaceutical company Meda is being acquired by Mylan, expanding Mylan's reach into emerging markets, building on its recent specialty and branded generics acquisitions and creating an OTC division worth about $1 billion. 

February 9, 2016

Walgreens will install safe medication disposal kiosks in more than 500 drug stores in 39 states and make naloxon available without a prescription at its pharmacies in 35 states. 

February 8, 2016
The aim of the partnership is to boost adherence among patients — something a recent study published in JAMA Internal Medicine has found can be improved by text message reminders.
February 8, 2016

Allergan's EVP and president branded pharma will take the reigns of Pfizer's consumer healthcare unit. 

February 4, 2016

Clinicians can better estimate the risk of glaucoma progression by looking at a readout from the smart lens. The findings could also have implications when using the lenses to evaluate glaucoma treatments.  

February 4, 2016

The Treato/MediaMiser survey determined that the doctor's office is still the location of choice to get the flu shot - 49% who got the flu shot went to see their doctor, followed by 19% at the pharmacy, 15% at place of employment and 11% at a health clinic. 

February 4, 2016
Flu season most often peaks in February in the U.S., Walgreens reported. 
February 3, 2016

The asthma treatment is a once-daily dose of two 1.25-microgram puffs. 

February 3, 2016
ZembraceSymTouch marks the first approval Dr. Reddy’s has received from the FDA for a brand-name product in its neurology portfolio. 
February 3, 2016

Reuters is reporting that in 2016, there will likely be seven blockbuster drugs launched, each of which has potential to see more than $1 billion in annual sales. The ones that are poised to be the biggest are a chronic liver desease drug from Intercept Pharmaceuticals and Gilead’s fixed-dose treatment for H.I.V, which experts forecast could make $2.6 billion and $2 billion, respectively. (Reuters)

February 2, 2016

CDC has received recent reports of severe respiratory illness among young- to middle-aged adults with H1N1pdm09 virus infection, some of whom required intensive care unit admission; fatalities have been reported. 

February 1, 2016

The availability of the antidote to opioid overdoses through retail pharmacy is increasing. 

February 1, 2016
The Chicago Tribune is reporting that pharmacy benefit manager Express Scripts has opted to block reimbursements for Valeant Pharmaceuticals’ Glumetza once the generic is launched on Feb. 1. According to GoodRx, the drug currently costs about $1,500 for a 30-day supply. “Recent agreements Valeant has signed with retail pharmacies now potentially encourage the pharmacies to bypass the more affordable generic,” Express Scripts said. “To protect our clients and patients from wasteful, unnecessary drug spend, Express Scripts will exclude Glumetza.” (Chicago Tribune)
 
January 29, 2016

The drug showed in clinical trials that it had a sustained antidepressant effect following a one-day rapid effect. 

January 29, 2016
The drug is delivered via the Xsail breath-powered delivery device, allowing intranasal dosing of the most commonly prescribed migraine treatment. 
January 29, 2016
The drug had previously received two breakthrough therapy designations from the FDA to treat chronic HCV GT1 infection in end-stage renal disease patients on hemodialysis, as well as for the treatment of chronic HCV GT4 infection. 
 
January 29, 2016

According to the New York Times, Valeant Pharmaceuticals has issued a statement following criticism from Hillary Clinton’s presidential campaign about it raising the cost of the drug D.H. E., noting that there was a generic version of the drug available and that it had less than 1% of the market share on D.H.E, which costs $14,000 for 10 vials, $11,000 more than it cost in June 2014. “Whenever the sales volume of a drug declines, manufacturers must consider pricing adjustments to keep production of the drug viable,” the company said.  (New York Times)

January 29, 2016
This week, Arizona ranks No. 2 in flu incidence among states and No. 3 in flu incidence gains, while Nevada tops the Walgreens Flu Index. 
 
January 28, 2016

The drug is a bioequivalent to Adderall XR and will be available in 3.1-, 6.3-, 9.4-, 12.5-, 15.7- and 18.8-mg dosage strengths. 

January 27, 2016

The company behind the first FDA approved drug created via 3D printing has secured financing led by Deerfield Management. 

January 27, 2016

The drug will be available in 30-mg delayed release disintegrating tablets, as well as 30- and 60-mg delayed release capsules. 

January 27, 2016

The ranking was created by creating overall scores based on the ratio of positive to negative medication reviews online by using TreatoVoice, which identifies and ranks patient experience base on their online postings. 

January 27, 2016

The Task Force found that patients who were identified through depression screening and went on to be treated — with antidepressant medication, psychotherapy or both — showed improvement in depression symptoms.